Purification of melanoma reactive T cell by using a monocyte-based solid phase T-cell selection system for adoptive...

Area of Science:

• Immunology
• Cell Therapy
• Biotechnology

Background:

• Adoptive cell therapy (ACT) for melanoma faces challenges in generating effective melanoma-reactive T cells.
• Clinical successes in ACT for melanoma drive innovation in T-cell generation technologies.

Purpose of the Study:

• To develop and validate a novel solid-phase T-cell selection system for purifying antigen-specific T cells.
• To improve the efficiency and purity of melanoma-reactive T cells for immunotherapy.

Main Methods:

• Immobilization of monocytes on a solid support for antigen-specific T-cell purification.
• Utilizing differential binding kinetics of antigen-specific T cells to immobilized monocytes.
• Washing away non-adherent cells to concentrate antigen-specific T cells.
• Assessing T-cell proliferation and purity post-selection.

Main Results:

• The system effectively concentrates antigen-specific T cells based on faster binding kinetics.
• Antigen-specific T cells demonstrated more rapid proliferation, increasing frequency and purity.
• T-cell selection increased tumor antigen-specific T-cell frequency by >10-fold, with further ~10-fold expansion post-selection.
• Generated T cells were produced under more physiologic conditions compared to traditional methods.

Conclusions:

• The novel solid-phase T-cell selection system is superior to traditional repeated stimulation methods for generating tumor antigen-specific T cells.
• This inexpensive and simple system can produce large quantities of highly purified Melan-A-specific T cells within two weeks.
• The developed method offers a promising advancement for adoptive cell immunotherapy in melanoma treatment.